NEW YORK (GenomeWeb) – The Scripps Research Institute (TSRI) announced today that it has partnered with Pfizer to develop a novel chemical synthesis technology for creating next-generation DNA-encoded libraries (DELs).

Under the terms of the deal, Pfizer will pay an undisclosed fee to gain access to a chemical synthesis technology developed at TSRI. The two will adapt this technology for use in creating DELs, and choose to expand their joint research to include other technologies enabling DEL-based drug discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.